Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label adverse drug reactions. Show all posts
Showing posts with label adverse drug reactions. Show all posts
Wednesday, March 07, 2012

no abstract: Sudden Death Related to Toxicity in a Patient on Capecitabine and Irinotecan Plus Bevacizumab Intake: Pharmacogenetic Implications

›
Sudden Death Related to Toxicity in a Patient on Capecitabine and Irinotecan Plus Bevacizumab Intake: Pharmacogenetic Implications : Laeti...
Thursday, March 01, 2012

Correspondence: Emergency Hospitalizations for Adverse Drug Events — NEJM

›
To the Editor: "We commend Budnitz and colleagues (Nov. 24 issue) 1 for their contribution to our understanding of emergency hos...
Saturday, May 21, 2011

abstract:Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial.

›
Friday, January 21, 2011

full free access: Preventable adverse drug events and their causes and contributing factors: the analysis of register data — Int J Qual Health Care (patient safety)

›
"In recent years, the number of patient complaints has also increased, probably because patients are more aware of their rights and mor...
Sunday, August 15, 2010

abstract: Expert Opinion on Drug Metabolism & Toxicology - Effects of herbal products on the metabolism and transport of anticancer agents

›
What the reader will gain: Potential interactions of herbal medicines with anticancer agents have become a safety concern in cancer chemoth...
Tuesday, July 20, 2010

Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions: patient/drug safety

›
Conclusions: This study validates that spontaneous reporting, despite its limitations, can be an important resource for detecting ADRs assoc...